Not for distribution to U.S. Newswire Solutions or for dissemination in the United States. INDIVA Supplies Update on Facility Expansion and Purchases Licensed Facility in London Ontario LONDON, ON – Wednesday, February 20, 2019: Indiva Restricted (the “Company” or “Indiva”) (TSXV:NDVA) (US:NDVAF) is pleased to deliver an update on its totally-funded expansion to 40,000 square feet at its facility in London, Ontario. The retrofit of three more flower rooms is now comprehensive and are presently undergoing common cleaning and sanitization procedures. The final video proof package was submitted to Overall health Canada on January 21st. After licensed by Overall health Canada, these three new rooms will promptly be populated with plants presently expanding in Indiva’s facility, and improve Indiva’s annual dry flower capacity to 1,000kg. By the finish of Q2, Indiva expects that dry flower capacity will improve to some three,000kg annually with the licensing of five more flower rooms. The Business is also pleased to announce the acquire of its facility at 1050 Hargrieve Rd. in London, Ontario pursuant to an agreement of acquire and sale dated November 28, 2018. The strategic selection to acquire the house reflects the reality that licenses granted beneath the Cannabis Act are tied to a precise address. With the $five.55 million money acquire of the house, Indiva now has secured extended-term certainty for the property of the organization’s operations. Additional, by owning the house it permits Indiva a higher capability for possible debt financing choices in the future and has streamlined the approach behind the planned creation of the Indiva farmgate shop (topic to AGCO approval). “Indiva’s expansion is on track, and we are excited to now totally personal the house which grows, and will manufacture, some of the highest high-quality cannabis and cannabis derivative goods on the marketplace,” stated Niel Marotta, President and CEO of Indiva.   Speak to Information and facts Niel Marotta, CEO, INDIVA Telephone: 613-883-8541 E mail: [email protected] Steve Low, Investor Relations Telephone: 647-620-5101 E mail: [email protected]   About Indiva Indiva aims to develop into a home of international marijuana brands, recognized for higher high-quality cannabis goods. Indiva’s wholly owned subsidiary is licensed beneath the Cannabis Act. As marijuana laws liberalize in Canada and internationally, Indiva will expand its solution supplying to contain secure edibles and other client- friendly cannabis goods. In Canada, Indiva will create and distribute Ruby Cannabis Sugar, Sapphire Salt, Ruby Gems, as nicely as award winning Bhang Chocolate and other derivative goods by way of license agreements and joint-ventures respectively. In addition, as marijuana laws liberalize internationally, Indiva will use its Canadian operations as a platform to open new markets for its cannabis goods.   DISCLAIMER & READER ADVISORY Neither the TSX Venture Exchange nor its Regulation Solutions Provider (as that term is defined in the policies of the TSX Venture Exchange) has in any way passed upon the merits of the Transaction and neither of the foregoing entities accepts duty for the adequacy or accuracy of this release or has in any way authorized or disapproved of the contents of this press release. Particular statements contained in this press release constitute forward-seeking data. These statements relate to future events or future efficiency. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and related expressions and statements relating to matters that are not historical details are intended to determine forward-seeking data and are primarily based on the parties’ existing belief or assumptions as to the outcome and timing of such future events. Actual future outcomes might differ materially. In unique, this release includes forward-seeking data relating to future licensing approvals, future expansion of expanding capacity, TSX Venture Exchange approval of the transactions contemplated herein, future international expansion, future solution offerings, future entry into more markets, alterations to laws and regulations in Canada and internationally, and compliance with applicable regulations. Different assumptions or elements are commonly applied in drawing conclusions or creating the forecasts or projections set out in forward-seeking data. These assumptions and elements are primarily based on data presently out there to the parties. The material elements and assumptions contain the parties becoming capable to acquire the essential corporate, regulatory and other third parties approvals licensing and other dangers related with regulated ACMPR entities and completion of satisfactory due diligence. The forward seeking data contained in this release is produced as of the date hereof and the parties are not obligated to update or revise any forward seeking data, regardless of whether as a outcome of new data, future events or otherwise, except as expected by applicable securities laws. Simply because of the dangers, uncertainties and assumptions contained herein, investors really should not spot undue reliance on forward seeking data. The foregoing statements expressly qualify any forward-seeking data contained herein. This press release does not constitute an give to sell or a solicitation of an give to obtain any of the securities in the United States. The securities have not been and will not be registered beneath the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and might not be supplied or sold inside the United States or to U.S. Persons unless registered beneath the U.S. Securities Act and applicable state securities laws or an exemption from such registration is out there. Not for distribution to U.S. Newswire Solutions or for dissemination in the United States. Any failure to comply with this restriction might constitute a violation of U.S. Securities laws.
The post Press Release – INDIVA Supplies Update on Facility Expansion and Purchases Licensed Facility in London Ontario appeared initial on INDIVA.